5 years ago 1 min read Two potential therapies from pharma giant Eli Lilly, an antibody drug and an arthritis pill, have seen promising trial results already this month. Continue Reading Previous J&J Tests Vaccine; France to Announce New Measures: Virus UpdateNext GoodRx jumps 40% in market debut Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. More Stories For Your Health 1 min read Record Korean Cases; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read California Hits Record; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push 5 years ago
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push